Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001472827-23-000005
Filing Date
2023-03-02
Accepted
2023-03-02 16:09:58
Documents
2
Period of Report
2023-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_167779137404576.html 3  
1 FORM 3 wf-form3_167779137404576.xml 3 1712
2 POWER OF ATTORNEY - SHEREEN SOLAIMAN powerofattorney_solaiman.txt EX-24 3694
  Complete submission text file 0001472827-23-000005.txt   6728
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address
Solaiman Shereen (Reporting) CIK: 0001472827 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-26642 | Film No.: 23699000